EU antitrust regulators send Johnson & Johnson (JNJ -0.1%) and Novartis (NVS -0.3%) a...
Thursday, January 31, 9:33 AM ETEU antitrust regulators send Johnson & Johnson (JNJ -0.1%) and Novartis (NVS -0.3%) a "statement of objections," or charge sheet, over a "co-promotion" deal they formulated that delayed the release of a generic competitor to J&J's painkiller fentanyl in Holland for 17 months in 2005-2006. The EU can levy fines of up to 10% of annual sales for anti-competitive behavior, although penalties are usually based on the revenues of the product involved. (PR)
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles